Prolia (denosumab) Disease area(s): Bone health Manufacturer(s): Amgen 2024 Sales (USD): $4.37 billion Why it sold so well: In 2024, Amgens Prolia achieved strong sales, with global revenues increasing by 8% year-over-year to $4.37 billion for the year, driven primarily by volume growth
Semaglutide is a glucagon-like peptide-1 receptor agonist that mimics your bodys GLP-1 hormone
Otherwise, oral and injectable semaglutide drugs have similar side effects, interactions, warnings, and costs
If you use Pandameds.com, please discuss all your medications with the prescribing doctor you consult through our platform
Semaglutide is a medication used to improve blood sugar control in adults with type 2 diabetes
[DOI] [Google Scholar] 67.Lakey-Beitia J., Burillo A.M., La Penna G., Hegde M.L., Rao K.S